Diphenyl diselenide alone and in combination with itraconazole against Sporothrix schenckii s.str. and Sporothrix globosa

Braz J Microbiol. 2021 Sep;52(3):1271-1274. doi: 10.1007/s42770-021-00506-2. Epub 2021 Apr 28.

Abstract

We evaluated the in vitro susceptibility of Sporothrix schenckii s.str. and Sporothrix globosa to diphenyl diselenide (PhSe)2 alone and in association with itraconazole (ITZ). Eight clinical isolates were tested in microdilution and checkerboard assays. (PhSe)2 alone inhibited all isolates in concentration ≤ 8 µg/mL and was effective in killing one S. schenckii isolate. Inhibitory and fungicidal beneficial effects in its interaction with ITZ were shown against 87.5% (7/8) and 50% (4/8) of the isolates tested, respectively. Our study demonstrates the in vitro antifungal activity of (PhSe)2 against two pathogenic Sporothrix species, suggesting studies of in vivo applications are warranted.

Keywords: Antifungal activity; Organoselenium compound; Sporotrichosis; Subcutaneous mycoses.

MeSH terms

  • Antifungal Agents* / pharmacology
  • Benzene Derivatives / pharmacology*
  • Itraconazole* / pharmacology
  • Microbial Sensitivity Tests
  • Organoselenium Compounds / pharmacology*
  • Sporothrix* / drug effects

Substances

  • Antifungal Agents
  • Benzene Derivatives
  • Organoselenium Compounds
  • diphenyldiselenide
  • Itraconazole

Supplementary concepts

  • Sporothrix globosa
  • Sporothrix schenckii